| 摘要 |
<p>A process for preparing a compound of formula (I):
or a tautomeric form thereof or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, wherein:
J represents O or S;
T represents a substituted or unsubstituted aryl group and T 1 is O or S;
which process comprises, reducing a compound of formula (II):
or a tautomeric form thereof or a salt thereof or a solvate thereof, wherein T and T 1 are as defined in relation to formula (I), with a complex hydride reducing agent or a source of a complex hydride reducing agent; and thereafter, as required, preparing a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate of the compound of formula (I) or a tautomeric form thereof.</p> |
